Clinical trial
SAVE-Care (SGLT2i As Novel Gout Care) Trial
NCT06674109 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SAVE-Care (SGLT2i As Novel Gout Care) Trial
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- July 1, 2026
- Completion date
- February 28, 2028
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gout and hyperuricemia